Theralase Technologies Inc. (TSXV:TLT) announced a non-brokered private placement of up to 4,095,157 units at a price of CAD 0.35 per unit for gross proceeds of CAD 1,433,305 on January 9, 2019. Each unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.50 per share for a period of 24 months. The company paid a finder’s fee of CAD 210 and issued 300 finder’s warrants to BMO Nesbitt Burns. Each finder’s warrant will entitle the holder to purchase one common share at an exercise price of CAD 0.50 per share for a period of 24 months. The transaction included participation from insiders for 542,857 units for gross proceeds of CAD 190,000. The securities issued in the transaction are subject to a hold period of four months and one day expiring on May 10, 2019. On January 9, 2019, the company announced that TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement. The transaction included participation from 31 placees insiders or pro group participation including Kristina Hachey for 100,000 shares, Roger Dumoulin-White for 200,000 shares, Randy Bruder for 28,571 shares and Guy Anderson for 214,286 shares.